Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke

Detalhes bibliográficos
Autor(a) principal: Zhang,Yang
Data de Publicação: 2019
Outros Autores: Zhang,Qing-Qing, Fu,Cong, Wang,Lei, Zhang,Guan-Qun, Cao,Pei-Wei, Chen,Guo-Fang, Fu,Xin-Min
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019001000603
Resumo: This study explores the safety and effect of acute cerebral infarction treatment by microcatheter injection of tirofiban combined with a Solitaire AB stent and/or stent implantation. Emergency cerebral angiograms showing the responsible vascular occlusion of 120 acute cerebral infarction patients who underwent emergency endovascular thrombectomy were included in the study. These patients were randomly divided into two groups using the random number table method: treatment group (n=60) that received thrombectomy (with cerebral artery stents) combined with intracerebral injection of tirofiban and control group (n=60) that only received thrombectomy (with cerebral artery stents alone). The baseline data, cerebral angiography before and after surgery, hospitalization, and follow-up results of patients in these two groups were compared. Furthermore, the incidence of major adverse cerebrovascular events of these two groups was compared (90-day modified Rankin scale, a score of 0–2 indicates a good prognosis). The difference between baseline clinical data and brain angiography between these two groups was not statistically significant. Patients in the treatment group had a higher prevalence of thrombolysis in cerebral infarction grade 2b/3 than patients in the control group (88.3% (53/60) vs 66.7% (40/60), P=0.036). Moreover, the National Institutes of Health Stroke Scale scores 7 days after surgery and the 90-day prognosis were all better for the patients who received tirofiban (P=0.048 and P=0.024). Mechanical thrombectomy with Solitaire AB stents in combination with the injection of tirofiban through a microcatheter appears to be safe and effective for the endovascular treatment of acute ischemic stroke.
id ABDC-1_4209bf7f3cf8caeb922861152ef622cd
oai_identifier_str oai:scielo:S0100-879X2019001000603
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic strokeAcute ischemic strokeSolitaire AB stentEndovascular thrombectomyTirofibanThis study explores the safety and effect of acute cerebral infarction treatment by microcatheter injection of tirofiban combined with a Solitaire AB stent and/or stent implantation. Emergency cerebral angiograms showing the responsible vascular occlusion of 120 acute cerebral infarction patients who underwent emergency endovascular thrombectomy were included in the study. These patients were randomly divided into two groups using the random number table method: treatment group (n=60) that received thrombectomy (with cerebral artery stents) combined with intracerebral injection of tirofiban and control group (n=60) that only received thrombectomy (with cerebral artery stents alone). The baseline data, cerebral angiography before and after surgery, hospitalization, and follow-up results of patients in these two groups were compared. Furthermore, the incidence of major adverse cerebrovascular events of these two groups was compared (90-day modified Rankin scale, a score of 0–2 indicates a good prognosis). The difference between baseline clinical data and brain angiography between these two groups was not statistically significant. Patients in the treatment group had a higher prevalence of thrombolysis in cerebral infarction grade 2b/3 than patients in the control group (88.3% (53/60) vs 66.7% (40/60), P=0.036). Moreover, the National Institutes of Health Stroke Scale scores 7 days after surgery and the 90-day prognosis were all better for the patients who received tirofiban (P=0.048 and P=0.024). Mechanical thrombectomy with Solitaire AB stents in combination with the injection of tirofiban through a microcatheter appears to be safe and effective for the endovascular treatment of acute ischemic stroke.Associação Brasileira de Divulgação Científica2019-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019001000603Brazilian Journal of Medical and Biological Research v.52 n.10 2019reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431x20198396info:eu-repo/semantics/openAccessZhang,YangZhang,Qing-QingFu,CongWang,LeiZhang,Guan-QunCao,Pei-WeiChen,Guo-FangFu,Xin-Mineng2019-09-13T00:00:00Zoai:scielo:S0100-879X2019001000603Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2019-09-13T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke
title Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke
spellingShingle Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke
Zhang,Yang
Acute ischemic stroke
Solitaire AB stent
Endovascular thrombectomy
Tirofiban
title_short Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke
title_full Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke
title_fullStr Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke
title_full_unstemmed Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke
title_sort Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke
author Zhang,Yang
author_facet Zhang,Yang
Zhang,Qing-Qing
Fu,Cong
Wang,Lei
Zhang,Guan-Qun
Cao,Pei-Wei
Chen,Guo-Fang
Fu,Xin-Min
author_role author
author2 Zhang,Qing-Qing
Fu,Cong
Wang,Lei
Zhang,Guan-Qun
Cao,Pei-Wei
Chen,Guo-Fang
Fu,Xin-Min
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Zhang,Yang
Zhang,Qing-Qing
Fu,Cong
Wang,Lei
Zhang,Guan-Qun
Cao,Pei-Wei
Chen,Guo-Fang
Fu,Xin-Min
dc.subject.por.fl_str_mv Acute ischemic stroke
Solitaire AB stent
Endovascular thrombectomy
Tirofiban
topic Acute ischemic stroke
Solitaire AB stent
Endovascular thrombectomy
Tirofiban
description This study explores the safety and effect of acute cerebral infarction treatment by microcatheter injection of tirofiban combined with a Solitaire AB stent and/or stent implantation. Emergency cerebral angiograms showing the responsible vascular occlusion of 120 acute cerebral infarction patients who underwent emergency endovascular thrombectomy were included in the study. These patients were randomly divided into two groups using the random number table method: treatment group (n=60) that received thrombectomy (with cerebral artery stents) combined with intracerebral injection of tirofiban and control group (n=60) that only received thrombectomy (with cerebral artery stents alone). The baseline data, cerebral angiography before and after surgery, hospitalization, and follow-up results of patients in these two groups were compared. Furthermore, the incidence of major adverse cerebrovascular events of these two groups was compared (90-day modified Rankin scale, a score of 0–2 indicates a good prognosis). The difference between baseline clinical data and brain angiography between these two groups was not statistically significant. Patients in the treatment group had a higher prevalence of thrombolysis in cerebral infarction grade 2b/3 than patients in the control group (88.3% (53/60) vs 66.7% (40/60), P=0.036). Moreover, the National Institutes of Health Stroke Scale scores 7 days after surgery and the 90-day prognosis were all better for the patients who received tirofiban (P=0.048 and P=0.024). Mechanical thrombectomy with Solitaire AB stents in combination with the injection of tirofiban through a microcatheter appears to be safe and effective for the endovascular treatment of acute ischemic stroke.
publishDate 2019
dc.date.none.fl_str_mv 2019-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019001000603
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019001000603
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1414-431x20198396
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.52 n.10 2019
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302947244638208